5 Best Healthcare Stocks to Buy According to Greg Martinez’s Parkman Healthcare Partners

2. Aclaris Therapeutics, Inc. (NASDAQ:ACRS)

Parkman Healthcare Partners’ Stake Value: $23,516,000

Percentage of Parkman Healthcare Partners’ 13F Portfolio: 5.94%

Number of Hedge Fund Holders: 36

Aclaris Therapeutics, Inc. (NASDAQ:ACRS) is a clinical-stage biopharmaceutical company engaged in developing drugs for immuno-inflammatory diseases. Greg Martinez, via Parkman Healthcare Partners, holds 1.3 million shares in Aclaris Therapeutics, Inc. (NASDAQ:ACRS), worth $23.5 million, representing 5.94% of the firm’s Q3 portfolio. 

As of Q3 2021, Rock Springs Capital Management is the leading Aclaris Therapeutics, Inc. (NASDAQ:ACRS) stakeholder, with 3.8 million shares amounting to $68.45 million. Overall, 36 hedge funds were long Aclaris Therapeutics, Inc. (NASDAQ:ACRS) in the third quarter, with the total stake value exceeding $470 million. 

On November 2, the Q3 EPS for Aclaris Therapeutics, Inc. (NASDAQ:ACRS) totaled -$0.35, missing EPS estimates by -$0.07. The $1.66 million revenue was up 14.49% year-over-year, but failed to meet analysts’ revenue estimates by -$111,670.